Author:
Nikravesh Fatemeh Yadavar,Shirkhani Samira,Bayat Elham,Talebkhan Yeganeh,Mirabzadeh Esmat,Sabzalinejad Masoumeh,Aliabadi Hooman Aghamirza Moghim,Nematollahi Leila,Ardakani Yalda Hosseinzadeh,Sardari Soroush
Abstract
AbstractGranulocyte colony stimulating factor (GCSF) can decrease mortality of patients undergo chemotherapy through increasing neutrophil counts. Many strategies have been developed to improve its blood circulating time. Albumin binding domain (ABD) was genetically fused to N-terminal end of GCSF encoding sequence and expressed as cytoplasmic inclusion bodies within Escherichia coli. Biological activity of ABD-GCSF protein was assessed by proliferation assay on NFS-60 cells. Physicochemical properties were analyzed through size exclusion chromatography, circular dichroism, intrinsic fluorescence spectroscopy and dynamic light scattering. Pharmacodynamics and pharmacokinetic properties were also investigated in a neutropenic rat model. CD and IFS spectra revealed that ABD fusion to GCSF did not significantly affect the secondary and tertiary structures of the molecule. DLS and SEC results indicated the absence of aggregation formation. EC50 value of the ABD-GCSF in proliferation of NFS-60 cells was 75.76 pg/ml after 72 h in comparison with control GCSF molecules (Filgrastim: 73.1 pg/ml and PEG-Filgrastim: 44.6 pg/ml). Animal studies of ABD-GCSF represented improved serum half-life (9.3 ± 0.7 h) and consequently reduced renal clearance (16.1 ± 1.4 ml/h.kg) in comparison with Filgrastim (1.7 ± 0.1 h). Enhanced neutrophils count following administration of ABD-GCSF was comparable with Filgrastim and weaker than PEG-Filgrastim treated rats. In vitro and in vivo results suggested the ABD fusion as a potential approach for improving GCSF properties.
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Panopoulos, A. D. & Watowich, S. S. Granulocyte colony-stimulating factor: Molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis. Cytokine 42, 277–288 (2008).
2. Schneider, A., Kuhn, H. G. & Schäbitz, W. R. A role for G-CSF (Granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4, 1753–1757 (2005).
3. Zhao, S. et al. Extending the serum half-life of G-CSF via fusion with the domain III of human serum albumin. Biomed. Res. Int. 2013, 1–8 (2013).
4. Tiwari, K. et al. Refolding of recombinant human granulocyte colony stimulating factor: Effect of cysteine/cystine redox system. Indian. J. Biochem. Biophys. 49, 285–288 (2012).
5. Solaroglu, I., Cahill, J., Jadhav, V. & Zhang, J. H. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37, 1123–1128 (2006).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献